trimetrexate
Sign in to saveTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
Research
520 papers- Trimetrexate.2012
- Trimetrexate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of Pneumocystis carinii pneumonia.Drugs · 1995
- Trimetrexate for Pneumocystis carinii pneumonia in patients with AIDS.The Annals of pharmacotherapy · 1992
- Trimetrexate: a second generation folate antagonist in clinical trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1987
- Trimetrexate: experience with solid tumors.Seminars in oncology · 1997
via PubMed
Wikidata facts
- Mass
- 369.1800895959999
- Has use
- medication
Show 6 more facts
- chemical formula
- C₁₉H₂₃N₅O₃
- canonical SMILES
- CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC
- defined daily dose
- 85
- medical condition treated
- pneumocystosis
- physically interacts with
- dihydrofolate reductase
- subject has role
- folic acid antagonists
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- Uses
- References
- External links
Trimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
==Uses== It has been used with leucovorin in treating pneumocystis pneumonia.
Excerpted from Wikipedia’s “trimetrexate” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0